Good point it's not a device like a Breather; an App; a Cervical Cancer Screening Device nor a Breast Implant so maybe not the best analogy. But success is tied to revenue and that has been in short supply for IMR.
I certainly wouldn't pay much attention as a holder to my thinking which is not very well informed. I was and still am looking for a med or health company which is trading on it's lows and has good growth potential. IMR fits that profile.
Your comment "it should come down to whether you believe the tech is good enough to generate revenue post-pandemic and if the expansion roadmap is realistic." is spot on.
Until there is some sign of sustainable revenue I can't make that assessment so I will continue to monitor. I wish you and Ben all the best. You both know the company much better than me.
IMR Price at posting:
$1.13 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)